BENDAMUSTINE HYDROCHLORIDE FOR INJECTION 25 MG
BENDAMUSTINE HYDROCHLORIDE : 25 MG · DIN 02498103 · MYLAN PHARMACEUTICALS ULC
Health Canada status: CANCELLED POST MARKET
What is BENDAMUSTINE HYDROCHLORIDE FOR INJECTION?
BENDAMUSTINE HYDROCHLORIDE FOR INJECTION 25 MG contains BENDAMUSTINE HYDROCHLORIDE : 25 MG. It is listed in the Health Canada Drug Product Database under DIN 02498103, held by MYLAN PHARMACEUTICALS ULC, supplied as POWDER FOR SOLUTION for INTRAVENOUS administration. Health Canada currently lists it as cancelled post market, status dated 25-Sep-2025. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02498103 |
|---|---|
| Brand name | BENDAMUSTINE HYDROCHLORIDE FOR INJECTION |
| Generic / active ingredient | BENDAMUSTINE HYDROCHLORIDE : 25 MG |
| Manufacturer | MYLAN PHARMACEUTICALS ULC |
| Strength | 25 MG |
| Dosage form | POWDER FOR SOLUTION |
| Route of administration | INTRAVENOUS |
| Schedule | Prescription |
| ATC code | L01AA09 BENDAMUSTINE |
| AHFS class | 10:00.00 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 25-Sep-2025 |
| Original market date | 2021-03-12 00:00:00 |
Is BENDAMUSTINE in shortage in Canada?
A Canadian shortage report is on file for this molecule: Resolved — reported by ACCORD HEALTHCARE INC, last seen 21 Aug 2026. A shortage on one presentation does not always affect every DIN of the molecule — the alternatives below list what else is marketed in Canada. Nexara can confirm current availability and identify substitutions or import options where permitted.
Check availability for BENDAMUSTINE HYDROCHLORIDE FOR INJECTION
What can be used instead?
Other Canadian products sharing ATC code L01AA09 BENDAMUSTINE. 11 of 18 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| BENDAMUSTINE HYDROCHLORIDE FOR INJECTION | 100 MG | POWDER FOR SOLUTION | ACCORD HEALTHCARE INC | MARKETED | DIN 02496860 |
| BENDAMUSTINE HYDROCHLORIDE FOR INJECTION | 100 MG | POWDER FOR SOLUTION | EUGIA PHARMA INC. | MARKETED | DIN 02542005 |
| BENDAMUSTINE HYDROCHLORIDE FOR INJECTION | 100 MG | POWDER FOR SOLUTION | AURO PHARMA INC | MARKETED | DIN 02509261 |
| BENDAMUSTINE HYDROCHLORIDE FOR INJECTION | 25 MG | POWDER FOR SOLUTION | AURO PHARMA INC | MARKETED | DIN 02509253 |
| BENDAMUSTINE HYDROCHLORIDE FOR INJECTION | 25 MG | POWDER FOR SOLUTION | ACCORD HEALTHCARE INC | MARKETED | DIN 02496852 |
| BENDAMUSTINE HYDROCHLORIDE FOR INJECTION | 25 MG | POWDER FOR SOLUTION | EUGIA PHARMA INC. | MARKETED | DIN 02541998 |
| BENVYON | 25 MG | SOLUTION | PFIZER CANADA ULC | MARKETED | DIN 02524309 |
| NAT-BENDAMUSTINE | 100 MG | POWDER FOR SOLUTION | NATCO PHARMA (CANADA) INC | MARKETED | DIN 02496895 |
| NAT-BENDAMUSTINE | 25 MG | POWDER FOR SOLUTION | NATCO PHARMA (CANADA) INC | MARKETED | DIN 02496887 |
| TREANDA | 100 MG | POWDER FOR SOLUTION | TEVA CANADA LIMITED | MARKETED | DIN 02392569 |
Who else supplies BENDAMUSTINE worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. BENDAMUSTINE appears in 80 registered pack listings across 9 markets, published on 7 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Request a quote for BENDAMUSTINE HYDROCHLORIDE FOR INJECTION
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.